Bar Ilan University Advertorial Information
“How Israel Can Win the PR War” Event in NYC to Address How Israel Can Overcome Negative Media Coverage
New York, NY, April 24, 2014 – At a time when Israel is increasingly experiencing negative media coverage due to the breakdown in the peace talks, people throughout the New York region are being urged to attend a special conversation on “How Israel Can Win the PR War.” This event will be held on Wednesday, May 28, 2014 at 7:30 pm at the Park Avenue Synagogue, 50 East 87th Street, at Madison Avenue. It is being presented by the American Friends of Bar-Ilan University (AFBIU) together with The Jewish Week.
The featured speakers will be Gerald Steinberg, professor of Political Science at Bar-Ilan University and founder of the Program on Conflict Management and Negotiation; and Gil Troy, professor of History at McGill University and a research fellow in the Shalom Hartman’s Engaging Israel program in Jerusalem. The conversation will be moderated by Linda Scherzer, director of The Jewish Week’s Write On For Israel /NY Program, and former CNN Mideast correspondent.
Prof. Steinberg is often sought out by media throughout the world for his cogent analysis of Middle East affairs. He is frequently quoted in the New York Times, and his op-ed columns appear in the Wall Street Journal, the Financial Times, Ha’aretz and the Jerusalem Post. Prof. Steinberg is the Founder/President of NGO Monitor, a Jerusalem-based public affairs institute awarded the 2013 Begin Prize.
Prof. Troy is a respected American presidential historian and Zionist activist. His two acclaimed books on Zionist topics are Why I am a Zionist and Moynihan’s Moment: America’s Fight Against Zionism as Racism. He writes a weekly column for the Jerusalem Post, and is Editor-at-Large of the “Open Zion” blog on The Daily Beast.
Tickets are $15 online; $20 at the door. Students can attend for free. Only cash or a check made payable to the American Friends of Bar-Ilan University will be accepted at the door. Space is limited, and people are advised to register in advance.
To purchase tickets, go to www.thejewishweek.com/PR-WARS. For further information about this event, please call 212-997-2906.
Lens developed at Bar-Ilan University to offer tactile sight for the blind
Prof. Zeev Zalevsky, head of the Electro-Optics study program at Bar-Ilan University’s Faculty of Engineering, has developed a bionic contact lens that has tremendous potential to enable the blind to see.
According to Zalevsky, the lens processes digital images and translates them into tactile sensations. These sensations can be felt on the person’s cornea, allowing him or her to form a picture of their physical surroundings.
“It’s like reading Braille, not with your fingertips but with your eyes,” said Zalevsky. He explains that the system uses a mounted camera or smartphone to capture images that are turned into a form of electronic Braille. Zalevsky said that with a short training the user can use the lens effectively.
Explaining that the device is worn just like a regular contact lens, Zalevsky said, “We can encode an image with many more points than the Braille systems, and use these to stimulate the surface of the cornea.” He added, “The more shapes you want to recognize, the longer the training should be. This is similar to how a visually impaired person learns Braille writing.”
Zalevsky and his research team is currently seeking funding to complete full-scale trials and move into mass production. He said that with the proper funding, the research and development period will be completed in approximately two years.
To learn more about ways to support Prof. Zalevsky’s research work to develop a bionic contact lens to enable the blind to see, call Howard Charish at 212-906-3900 or email email@example.com.
Bar-Ilan University battery pioneer awarded for tech advances
Israel’s most well-known battery scientist, Professor Doron Aurbach of Bar-Ilan University, was recently awarded the prestigious International Battery Association (IBA) Yeager Award for his work in advancing battery technology.
Aurbach conducts his research work at the Nano Cleantech Center at the Bar-Ilan University Institute of Nanotechnology and Advanced Materials (BINA). He is a pioneer in the development of the lithium-ion batteries used to power personal devices.
His most promising new project is based on the magnesium ion, which supplies more power than lithium-ion batteries. Magnesium ion batteries would be less expensive to produce. By using nano-materials to tweak individual cells, Aurbach believes the new batteries would be smaller, lighter and last 50%-100% longer than current ones.
There is tremendous corporate interest in Aurbach’s work. His lab currently partners with General Motors and BASF, along with Israeli companies Elbit, Tadiran and Vulcan. Bar-Ilan itself works with several battery start-ups, including ETV Energy and Pellion Technologies.
Talking about the fast development of magnesium ion batteries, Aurbach said, “The first batteries from ETV Energy should be ready for the market at the end of the year.” Several projects with BASF are nearing completion. He added, “Within a year or so we will see some of these innovations in cellphones, with as much as a 50% improvement in performance.
Realizing that improved car batteries are the “golden ticket” in the battery business, Aurbach is continuing to improve upon his work to develop a less expensive electric car battery with double the range and half the weight of current batteries. “If our research is successful, they will be available sooner rather than later,” he said.
To learn more about ways to support Prof. Aurbach’s research work to develop nano-batteries for electric cars, call Howard Charish at 212-906-3900 or email firstname.lastname@example.org.
Israeli Scientists from Harvard, Yale, Stanford & Other World-class Universities Returning to Israel to Advance Cancer Research
|Top Doctors and Researchers Returning to Israel to Teach at Bar-Ilan University’s Medical School in Safed|
Much has been written about Israel's "brain drain;" much less about "Returning Scientists" trained at the best institutes around the world. It is the need to keep Israel's scientific brainpower in the country that spurred Bar-Ilan University to absorb 50 Returning Scientists at its Ramat Gan campus. This mission was expanded two years ago when the Israeli government chose Bar-Ilan to create the country's first new medical school in 40 years, endorsing it unique vision of…
- Creating a Medical Research Institute built along the lines of the best American medical schools.
- Partnering with six existing Galilee hospitals to save money.
- Staffing the School with “the best and brightest Returning Scientists from around the world.
So far, the Bar-Ilan University Medical School has recruited 17 faculty members from leading overseas academic and medical institutions, including Harvard, Yale, Stanford, the National Institutes of Health (NIH) and Sloan-Kettering.
Many of the returning scientists are sponsored by private foundations, like the Dr. Stanley & Hana Goldberg Research Fund, which supports Prof. Izhak Haviv, Head of Cancer Genomics and Diagnostics at the Medical School. He is returning from the Peter MacCallum Cancer Centre in Australia. Prof. Haviv is analyzing the biochemical relationships between cancer victims and their tumors. We can now better predict how cancer patients will respond to a drug by observing how mutations react in many cancers.
Another returning scientist is Dr. Hava Gil-Henn. She is continuing the work begun at Yale to examine cellular migration – a process at the heart of better understanding the immune response to cancer.
Dr. Michael Blank comes to the School via the NIH. His special interest is the molecular mechanisms that regulate cell growth and lead to the formation of tumors. He is focusing on the study of a tumor suppressor gene that he and his teammates discovered while he was at the NIH.
“It’s called Smurf2,” he says with a chuckle, well aware that, for most people, the name of this anticancer molecule conjures an image of blue fictional creatures. “Smurf2 is a gene that inhibits the transformation of normal cells to cancer cells.”
To learn more about matching gift partnership opportunities to build the new Bar-Ilan Medical School facility, including research labs or the Returning Scientist sponsorships, go to: www.afbiu.org, call Howard Charish at 212-906-3900 or email email@example.com
Israel’s doctor shortage being addressed by Bar-Ilan University Medical School
|Key to strategy to upgrade healthcare in Galilee|
Israel’s anticipated shortage of doctors in the next two years, as noted by a blue-ribbon governmental commission, hastened the creation of Bar-Ilan University’s Medical School – the country’s first new medical school in nearly 40 years.
Now beginning its third year of operation at its initial site in Safed, the School is moving swiftly to upgrade medical facilities in the North. It is partnering with six Galilee hospitals, which have made 75 staff appointments (including 52 MDs) while providing hospital-based clinical training to 412 students since the School’s opening.
The School’s achievements validate why the Israeli government chose Bar-Ilan to create the Faculty of Medicine.
The government cited Bar-Ilan’s vision of creating a Medical Research Institute that will be built along the lines of the National Institutes of Health (NIH) in the United States.
According to Prof. Ran Tur-Kaspa, Medical School Dean, the School has quickly embarked upon an innovative approach of disease-targeted research which will provide realistic and practicable solutions to specific human illness.
In choosing Bar-Ilan for this project, the government also cited the University’s underlying ideological mission to strengthen and enrich Israeli society and reach out to the disadvantaged in Israel’s periphery.
Praising this initiative, Dr. Masad Barhoum, Director General of the Western Galilee Hospital, said, “Social justice means the right to equal healthcare at a high level, regardless of where you live.”